Related references
Note: Only part of the references are listed.Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
Jingsi Dong et al.
FRONTIERS IN PHARMACOLOGY (2019)
Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma
Yunyang Chen et al.
SCIENTIFIC REPORTS (2019)
Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer
Jingsi Dong et al.
PLOS ONE (2019)
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
C. R. Lindsay et al.
EUROPEAN JOURNAL OF CANCER (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma
Lu-Nan Qi et al.
CANCER RESEARCH (2018)
Circulating tumor cells count as a predictor of survival in lung cancer
Konstantinos Syrigos et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study
Melissa A. Frick et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges
Etienne Giroux Leprieur et al.
EUROPEAN JOURNAL OF CANCER (2017)
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance
Zhen Wang et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy
Charu Aggarwal et al.
LUNG CANCER (2017)
Systematic Correlation Analyses of Circulating Tumor Cells with Clinical Variables and Tumor Markers in Lung Cancer Patients
Xu Wang et al.
JOURNAL OF CANCER (2017)
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers
Vasudha Murlidhar et al.
CANCER RESEARCH (2017)
A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups
C. R. Lindsay et al.
ANNALS OF ONCOLOGY (2017)
Are ALK rearrangement variants promising predictive biomarker of ALK tyrosine kinase inhibitors efficacy?
M. Duruisseaux et al.
ANNALS OF ONCOLOGY (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients
Yong-kang Liu et al.
HEPATOLOGY INTERNATIONAL (2016)
Distribution and clinical significance of circulating tumor cells in nasopharyngeal carcinoma
Yongfeng Si et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis
Hossein Borghaei et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology
Marco Wendel et al.
PHYSICAL BIOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients
Yoshitomo Okumura et al.
ANNALS OF THORACIC SURGERY (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Share Paper
